Literature DB >> 2021585

The antineutrophil antibody in uveitis.

D W Young1.   

Abstract

Ninety eight patients with uveitis of various types were tested for the presence of the antineutrophil antibody or ANCA by an indirect immunofluorescence method. This antibody is found in patients with diseases associated with small vessel vasculitis, including Wegener's granulomatosis and microscopic polyarteritis. Eleven true positive cases were found. A positive test was not associated with the anatomical site of the uveitis but was related to the time course of the disease. In particular single/repeated rather than nonrecurrent uveitis was associated with a positive test. Three groups of patients seem more likely to have positive tests: those with bilateral chronic posterior uveitis; a group with an anterior uveitis which is single/repeated who were younger than 46 at disease onset and had isolated eye disease; and an older group, aged 60 years or more at onset, with single/repeated uveitis and systemic features.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021585      PMCID: PMC1042321          DOI: 10.1136/bjo.75.4.208

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

2.  Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988.

Authors:  N Rasmussen; A Wiik
Journal:  APMIS Suppl       Date:  1989

Review 3.  Autoimmunity in rapidly progressive glomerulonephritis.

Authors:  C D Pusey; C M Lockwood
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

4.  Changing patterns of uveitis.

Authors:  D E Henderly; A J Genstler; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

5.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

Authors:  D J Davies; J E Moran; J F Niall; G B Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

6.  The International Uveitis Study Group.

Authors:  K M Saari
Journal:  Acta Ophthalmol Suppl       Date:  1984

7.  Microscopic polyarteritis: presentation, pathology and prognosis.

Authors:  C O Savage; C G Winearls; D J Evans; A J Rees; C M Lockwood
Journal:  Q J Med       Date:  1985-08

8.  Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis.

Authors:  C M Lockwood; D Bakes; S Jones; K B Whitaker; D W Moss; C O Savage
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

9.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

  9 in total
  4 in total

1.  pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.

Authors:  L K Gordon; M Eggena; G N Holland; J M Weisz; J Braun
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

Review 2.  Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review.

Authors:  Toshihiko Matsuo
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

3.  Uveitis and anti-neutrophil cytoplasmic antibodies.

Authors:  E C Hagen; H van de Vijver-Reenalda; R J de Keizer; A Kijlstra; L A van Es; M R Daha; F J van der Woude
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 4.  Immunological tests and their interpretation in uveitis.

Authors:  S R Rathinam; Ilknur Tugal-Tutkun; Mamta Agarwal; Vedhanayaki Rajesh; Merih Egriparmak; Gazal Patnaik
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.